
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Manual for 10 Scrumptious Specialty Mixed drinks - 2
Storm Goretti sweeps United Kingdom, France with winds over 120 mph - 3
Passover under fire: Israelis balance fatigue with cautious hope after month of war - 4
The most effective method to Explore Moral Situations in Brain research with Your Certification - 5
The Beginning Of The End For Fossil Fuels Can Start In Colombia
Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
Vote in favor of your Favored Kind of Scarf
The Incomparable Advanced cameras: Which One Will Win?
Language Learning Stages: Which One Gets Your Vote?
Is relief in sight? Flu season still brutal but cases are declining.
Damaged launch pad: How long before Russia can send astronauts to the ISS again?
NASA Perseverance rover sees megaripples on Mars | Space photo of the day for Jan. 7, 2026.
Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more













